Medical supervision helps reduce guesswork
Our focus is safety, appropriate monitoring, and individualized medical care
5 Specific enzymes in intracellular lysosomes or tumor microenvironments can selectively break the linker, for example, proteases in lysosomes hydrolyzing peptide bonds contained in dipeptide or tetrapeptide linkers, glycosidases hydrolyzing -glucuronides and -galactosides, phosphatases hydrolyzing phosphoesters and pyrophosphates, and sulfatases hydrolyzing sulfates
From the obtained 221 studies, we selected 63 papers
"Better" depends on individual response, tolerance, medical history, and specific metabolic goals
244,247 These limitations underscore key bottlenecks in drug development rather than undermining the therapeutic relevance of SIRT1